{
    "xml": "<topic id=\"PHP6035\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/gelatin\" basename=\"gelatin\" title=\"GELATIN\">\n<title>GELATIN</title>\n<body>\n<data name=\"vtmid\">420778005</data>\n<data name=\"vtmid\">79138004</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_222173039\" title=\"Plasma substitutes\">Plasma substitutes</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP46227\" outputclass=\"indicationsAndDose\" rev=\"1.20\" parent=\"/drugs/gelatin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Low blood volume in hypovolaemic shock, burns and cardiopulmonary bypass</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 500&#8211;1000&#8239;mL, use 3.5&#8211;4% solution.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46323\" outputclass=\"cautions\" rev=\"1.11\" parent=\"/drugs/gelatin\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Cardiac disease</ph>; <ph outputclass=\"caution\">severe liver disease</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46166\" outputclass=\"sideEffects\" rev=\"1.11\" parent=\"/drugs/gelatin\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Severe anaphylactic reactions</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Hypersensitivity reactions</ph>; <ph outputclass=\"sideEffect\">transient increase in bleeding time</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46205\" outputclass=\"pregnancy\" parent=\"/drugs/gelatin\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer of <i>Geloplasma</i>\n<tm tmtype=\"reg\"/> advises avoid at the end of pregnancy.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46239\" outputclass=\"hepaticImpairment\" parent=\"/drugs/gelatin\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46187\" outputclass=\"renalImpairment\" parent=\"/drugs/gelatin\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution in renal impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46124\" outputclass=\"monitoringRequirements\" parent=\"/drugs/gelatin\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Urine output should be monitored. Care should be taken to avoid haematocrit concentration from falling below 25&#8211;30% and the patient should be monitored for hypersensitivity reactions.</p>\n</sectiondiv>\n<sectiondiv>\n<p>Plasma and plasma substitutes are often used in very ill patients whose condition is unstable. Therefore, close monitoring is required and fluid and electrolyte therapy should be adjusted according to the patient&#8217;s condition at all times.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60512\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.11\" parent=\"/drugs/gelatin\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>The gelatin is partially degraded.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP6035-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/gelatin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77903\" title=\"Infusion\" namespace=\"/drugs/gelatin/infusion\">Infusion</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78566\" namespace=\"/treatment-summaries/fluids-and-electrolytes\" title=\"Fluids and electrolytes\" count=\"3\" rel=\"backlink\">Fluids and electrolytes</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77903\" namespace=\"/drugs/gelatin/infusion\" title=\"Infusion\" count=\"1\" rel=\"link\">Infusion</xref>\n</links>\n</topic>",
    "id": "PHP6035",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/gelatin",
    "basename": "gelatin",
    "title": "GELATIN",
    "vtmid": "79138004",
    "drugClassification": [
        "Plasma substitutes"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Low blood volume in hypovolaemic shock, burns and cardiopulmonary bypass",
                        "html": "Low blood volume in hypovolaemic shock, burns and cardiopulmonary bypass"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 500&#8211;1000 mL, use 3.5&#8211;4% solution.",
                        "html": "<p>Initially 500&#8211;1000&#8239;mL, use 3.5&#8211;4% solution.</p>"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Cardiac disease",
                "html": "Cardiac disease"
            },
            {
                "type": "cautions",
                "textContent": "severe liver disease",
                "html": "severe liver disease"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Severe anaphylactic reactions",
                        "html": "Severe anaphylactic reactions",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Hypersensitivity reactions",
                        "html": "Hypersensitivity reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "transient increase in bleeding time",
                        "html": "transient increase in bleeding time",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer of Geloplasma advises avoid at the end of pregnancy.",
                "html": "<p>Manufacturer of <i>Geloplasma</i>\n<tm tmtype=\"reg\"/> advises avoid at the end of pregnancy.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution in severe impairment.",
                "html": "<p>Use with caution in severe impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution in renal impairment.",
                "html": "<p>Use with caution in renal impairment.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Urine output should be monitored. Care should be taken to avoid haematocrit concentration from falling below 25&#8211;30% and the patient should be monitored for hypersensitivity reactions.",
                "html": "<p>Urine output should be monitored. Care should be taken to avoid haematocrit concentration from falling below 25&#8211;30% and the patient should be monitored for hypersensitivity reactions.</p>"
            },
            {
                "type": "patientParameters",
                "textContent": "Plasma and plasma substitutes are often used in very ill patients whose condition is unstable. Therefore, close monitoring is required and fluid and electrolyte therapy should be adjusted according to the patient&#8217;s condition at all times.",
                "html": "<p>Plasma and plasma substitutes are often used in very ill patients whose condition is unstable. Therefore, close monitoring is required and fluid and electrolyte therapy should be adjusted according to the patient&#8217;s condition at all times.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "The gelatin is partially degraded.",
                "html": "<p>The gelatin is partially degraded.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77903",
                "label": "Infusion",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78566",
                "label": "Fluids and electrolytes",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77903",
                "label": "Infusion",
                "type": "medicinalForm"
            }
        ]
    }
}